BridgeBio Oncology Therapeutics Funding: $200M Raised

BridgeBio Oncology Therapeutics is based in Palo Alto, California. It has raised $200M in total funding. Latest round: Growth.

BridgeBio Oncology Therapeutics funding overview

BridgeBio Oncology Therapeutics is based in Palo Alto, California. BridgeBio Oncology Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in May 2024. The round record for BridgeBio Oncology Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management and 5 others. 11 distinct backers are named across the disclosed rounds.

BridgeBio Oncology Therapeutics at a glance

Total raised
$200M
Latest round
Growth
Latest round date
May 2024
Headquarters
Palo Alto, California
Notable investors
Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital (a Citadel company)

Frequently asked about BridgeBio Oncology Therapeutics funding

How much has BridgeBio Oncology Therapeutics raised?
BridgeBio Oncology Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in BridgeBio Oncology Therapeutics?
Cormorant Asset Management, Omega Funds, Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management are named among the investors backing BridgeBio Oncology Therapeutics.
What was the latest BridgeBio Oncology Therapeutics funding round?
The most recent disclosed round is a Growth, announced in May 2024.
Where is BridgeBio Oncology Therapeutics based?
BridgeBio Oncology Therapeutics is based in Palo Alto, California.
When did BridgeBio Oncology Therapeutics last raise?
The last disclosed BridgeBio Oncology Therapeutics round closed in May 2024 at Growth.

Totals shown for BridgeBio Oncology Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Palo Alto and the investors behind them below.

Companies related to BridgeBio Oncology Therapeutics (36)

Browse related funding lists (11)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades